-
L-NMMA acetate: NOS Pathway Research Workflows
2026-08-20
L-NMMA acetate provides a practical way to test whether nitric oxide signaling drives osteogenic, inflammatory, or vascular phenotypes. This guide translates dental follicle cell findings into controlled dose-response workflows, pathway readouts, and troubleshooting decisions.
-
X-Gal and iRhom2: From Clones to Olfactory Biology
2026-08-20
A translational framework for using X-Gal and lacZ reporters to improve construct validation while interpreting iRhom2-dependent olfactory signaling with appropriate mechanistic caution.
-
Coronavirus Macrodomains and PARP-Mediated Antiviral Defense
2026-08-19
The reference study shows that coronavirus macrodomains counter host ADP-ribosylation by preventing PARP-dependent restriction of viral replication and supporting interferon regulation. Pharmacological inhibition and targeted depletion identify PARP12 and PARP14 as important components of this antiviral response, providing a mechanistic framework for studying coronavirus immune evasion.
-
Imipramine: A Causal Autophagy Assay Framework
2026-08-19
Imipramine can support integrated autophagy and apoptosis research, but its value depends on distinguishing pathway modulation from endpoint artifacts. This guide adapts lipidomics-based causal reasoning to glioma, leukemia, neuroscience, and immunology assays without overstating cross-domain evidence.
-
Nutlin-3a and Ferroptosis: A p53 Assay Framework
2026-08-18
Nutlin-3a is a potent MDM2 inhibitor for dissecting p53 pathway activation, cell-cycle control, and apoptosis. This article develops a distinct assay framework that connects MDM2–p53 experiments with the ferroptosis and migration biology described in glioblastoma research.
-
Pexmetinib (ARRY-614) for Cytokine Assays
2026-08-18
Pexmetinib (ARRY-614) gives researchers a practical way to examine inflammatory cytokine inhibition alongside Tie2-linked signaling. This workflow uses concentration bracketing, whole-blood validation, phospho-protein controls, and dephosphorylation assays to distinguish direct pathway modulation from nonspecific toxicity.
-
Direct Mouse Genotyping Kit Plus for SCA3 Models
2026-08-17
Discover how the Direct Mouse Genotyping Kit Plus can strengthen genotype-to-phenotype workflows in SCA3/MJD mouse research. This article connects direct tissue lysate PCR with experimental design, model authentication, and interpretation of neuroinflammation and autophagy findings.
-
Glabridin–Gold(I) Complex Reprograms Tumor Immunity
2026-08-17
The 2025 Advanced Science study develops glabridin–gold(I) complex 6d as an immunomodulatory agent designed to inhibit TrxR and MAPK signaling simultaneously. In liver cancer models, 6d increased dendritic-cell maturation, reduced several immunosuppressive immune populations, lowered tumor-cell PD-L1, and enhanced T-cell granzyme B production, providing a mechanistic rationale for combination immunotherapy studies.
-
Cryptosporidium AdhE: Imidazole Inhibition and Efficacy
2026-08-16
The reference study establishes the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a chemically tractable target in Cryptosporidium parvum. Screening and follow-up experiments connect lower-micromolar enzyme inhibition by selected antifungal imidazoles with suppression of parasite growth in vitro, while also defining important limits for target validation and therapeutic translation.
-
RIPostC, Ketone Bodies, and Ferroptosis in Stroke
2026-08-15
This ACS Chemical Neuroscience study identifies ketone body metabolism as a mechanistic link between remote ischemic postconditioning and neuroprotection after ischemic stroke. Rat and neuronal-cell experiments connect the intervention with improved energy status, reduced iron-dependent lipid peroxidation, preservation of GPX4, and suppression of ACSL4, while also defining important limits for translating ketone-body findings into metabolite-specific studies.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-08-14
Song and colleagues show that murine norovirus uses NINJ1-mediated plasma membrane rupture as part of an unconventional, selective route for releasing the viral protein NS1. The study connects caspase-3 cleavage, NINJ1 recruitment to viral replication sites, and NS1–NINJ1 interaction, while demonstrating that this pathway contributes to oral infection in mice.
-
iPSC Trial Selection for Ultrarare Disease
2026-08-14
The reference study developed a patient-specific iPSC platform to prescreen therapies for an ultrarare ECHS1-related Leigh-like syndrome before further clinical-trial decisions. Its key contribution is a multisystem, control-based workflow that connected cellular drug responses with a subsequent three-year patient treatment experience, while also clarifying the limits of extrapolating results across genetically distinct disorders.
-
CPI-613 Workflows for Cancer Metabolism Studies
2026-08-13
Build reproducible tumor cell metabolism studies around CPI-613 with dose–time pilots, orthogonal mitochondrial readouts, and combination-testing strategies. The workflow also translates recent cholangiocarcinoma findings into practical assays for PDHA1 activity, α-ketoglutarate accumulation, apoptosis, and macrophage antigen presentation.
-
Ceruletide: Designing Better Pancreatic Fibrosis Assays
2026-08-13
Ceruletide, also known as Caerulein, is more than a secretagogue: it is a controllable physiological input for connecting pancreatic injury models with fibrosis biology. This guide explains how to use its receptor-driven effects, product specifications, and mechanistic study design to improve pancreatic function research and assay interpretation.
-
Sumatriptan Metabolism: CYP and MAO Revisited
2026-08-12
The reference study challenges the prevailing view that sumatriptan is metabolized mainly through MAO A-mediated oxidative deamination. Using recombinant human enzymes and HPLC–MS, it identifies CYP1A2, CYP2C19, and CYP2D6 as contributors to sequential N-demethylation, while confirming selective MAO A activity toward the parent drug and its desmethyl metabolites.